HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ASA Ruling On IMEDEEN Beauty Drink Illustrates Nutricosmetic Challenge In EU

This article was originally published in The Rose Sheet

Executive Summary

If you're in the nutricosmetics game, the EU is the place to be, market researchers suggest. However, European regulations for health claims on food products put nutricosmetic brands in a tight spot.

You may also be interested in...



Nutricosmetics Pose Intriguing Possibilities For Brands That Hit Wall With Skin-Care Claims

Statements about collagen production, maintaining cellular integrity, addressing age spots, even shrinking wrinkles and treating noncystic acne – all are viable structure/function claims for nutricosmetics, assuming there's evidence to back them up. The Rose Sheet discusses the growing opportunity with regulatory and legal experts and provides an overview of the market at present.

In Brief

The Sunscreen Innovation Act passes with President Obama’s autograph; movement to ban cosmetic animal-testing in Australia gains momentum. More news in brief.

Nutricosmetic Opportunity Still Viable, But Firms Must Invest In Outreach

Rather than “standing behind the brands,” nutricosmetic manufacturers are “just making a product and expecting a consumer to understand,” says brand consultant Paula Simpson. Consumers – particularly those in North America, who tend to expect immediate results – must be educated about nutricosmetics, which often take weeks or months to have an impact, she suggests.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121396

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel